World’ s first transgenic pigs used to evaluate the drug efficacy
for treating Alzheimer’ s disease (AD), cell line clinical-grade allogeneic embryonic
stem cell-derived mesenchymal stem cell therapy platform MMSC
Clinical-grade allogeneic embryonic
stem-cell-derived mesenchymal stem cell
Severe inflammatory disease with
unexplained bladder tissue damage
where over 90% of patients are female.
We produce transgenic pigs that express
all three APP, TAU, and PS1 genes that induce
beta-amyloid and Tau protein deposition.
The lights at Mirae Cell Bio laboratories will never go out until
we make the impossible possible.
Mirae Cell Bio possesses medical therapy manufacturing facilities used for the production of cell therapy agents. Under the belief that quality should be our top priority, we operate our entire production cycle (from receiving raw materials to shipment of products) according to GMP regulations, and we have received ISO 9001 and ISO14001 certifications.
Allogeneic embryonic stem cell-derived
mesenchymal stem cells
Cloned AD Pig that Simultaneously Expresses
Three of Causative Genes of AD
Stem Cell-Derived Useful
Investigator Initiated Trial (IIT)
Sponsor Initiated Trial (SIT)